Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    HSP

News SummaryMost relevantAll newsSector news 

Hospira : Applauds Delaware Governor’s Signing of Biosimilars Legislation

05/30/2014 | 12:42pm US/Eastern

LAKE FOREST, Ill., May 30, 2014 - Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today commended Delaware Gov. Jack Markell for his decision to sign Senate Substitute 1 for Senate Bill 118. This law creates a pathway for the substitution of interchangeable biologic drugs and helps pave the way for patient access to cost savings from biosimilar products.

When biosimilars become available in the United States in the coming years, clinicians will have opportunities to provide their patients with greater accessibility to effective and more affordable biologic drugs. The introduction of biosimilars could help the United States save up to $250 billion over 10 years, according to one report.

"The introduction of biosimilars promises to help put new cost-savings in the hands of patients and states, such as Delaware, that are taking early action to establish clear and transparent policies for the substitution of these high-quality and more affordable biologic products," said Paul Audhya, M.D., vice president, Medical Affairs, Hospira.

The governor's signature on Senate Substitute 1 for Senate Bill 118 allows pharmacists to substitute biosimilars for prescribed biological reference products unless the prescribing physician expressly requests the reference biologic.

Hospira is a market leader in biosimilars in Europe, and expects to submit its first biosimilar to the U.S. Food and Drug Administration (FDA) later this year or in early 2015.

distributed by
React to this article
Latest news on HOSPIRA, INC.
09/08 ARRAY BIOPHARMA : cfo steps down, replacement named. (BRIEF)
09/05 HOSPIRA : A $90 million payday for Hospira CEO after sale to Pfizer
09/03 PFIZER : completes acquisition of injectable drugmaker Hospira
09/03 HOSPIRA : Termination of a Material Definitive Agreement, Completion of Acquisit..
09/02 HOSPIRA : and Cerner Expand Agreement to Advance Integration of I.V.-EMR Technol..
09/02 PFIZER : Receives Clearance from U.S. Federal Trade Commission for Hospira Acqui..
09/02 HOSPIRA : Announces First Installation of Plum 360 Infusion System With Hospira ..
09/01 S&P 500 Plans to Add Activision Blizzard, United Continental Holdings
08/31 BRIEF : United Airlines to enter S&P 500, replacing Hospira
08/31 PFIZER : Gets Clearance from U.S. FTC for Hospira Acquisition
Income Statement Evolution
More Financials